Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4752040
Max Phase: Preclinical
Molecular Formula: C51H68N8O15S
Molecular Weight: 1065.21
Molecule Type: Unknown
Associated Items:
ID: ALA4752040
Max Phase: Preclinical
Molecular Formula: C51H68N8O15S
Molecular Weight: 1065.21
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOCCOCCOCCOCCOCC(=O)NCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)C(C)(C)C)cc1
Standard InChI: InChI=1S/C51H68N8O15S/c1-32-44(75-31-55-32)34-10-8-33(9-11-34)27-54-46(64)39-26-35(60)28-58(39)50(68)45(51(2,3)4)56-42(63)30-74-25-23-72-21-19-70-17-16-69-18-20-71-22-24-73-29-41(62)53-15-14-52-37-7-5-6-36-43(37)49(67)59(48(36)66)38-12-13-40(61)57-47(38)65/h5-11,31,35,38-39,45,52,60H,12-30H2,1-4H3,(H,53,62)(H,54,64)(H,56,63)(H,57,61,65)/t35-,38?,39+,45-/m1/s1
Standard InChI Key: RYUOWYBJHFPQOX-UTKYEEBISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1065.21 | Molecular Weight (Monoisotopic): 1064.4525 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Girardini M,Maniaci C,Hughes SJ,Testa A,Ciulli A. (2019) Cereblon versus VHL: Hijacking E3 ligases against each other using PROTACs., 27 (12.0): [PMID:30826187] [10.1016/j.bmc.2019.02.048] |
Source(1):